Difference between revisions of "Fluoxetine-hypericum"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{ Drugswitch | from = fluoxetine | to = hypericum | stop = * '''Before day 0:''' gradually reduce dosage of fluoxetine to a maximum of 20 mg/day, when this dosage is > 20 mg...')
 
Line 6: Line 6:
 
* '''Day 1:''' stop administration of fluoxetine.
 
* '''Day 1:''' stop administration of fluoxetine.
 
| start =  
 
| start =  
* '''Day 1-42:''' a wash-out period of five weeks is necessary.
+
Caution is necessary.
* '''Day 43:''' start administration of hypericum in a dosage of 300 mg three times a day (900 mg/day).
+
* '''Day 1-28:''' a wash-out period of four weeks is necessary.
 +
* '''Day 29:''' start administration of hypericum in a dosage of 300 mg three times a day (900 mg/day).
 
| info =  
 
| info =  
 
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.}}
 
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.}}

Revision as of 13:02, 7 May 2009

Fluoxetine
Type Antidepressant
Group SSRI
links
Medscape Fluoxetine
PubChem 3386
PubMed Fluoxetine
Kompas (Dutch) Fluoxetine
Wikipedia Fluoxetine
Hypericum
Type Antidepressant
Group other
links
EMEA 10130408en
PubMed Hypericum
Kompas (Dutch) hypericum extract
Wikipedia St John's wort

Switch medication from fluoxetine to hypericum.[1] [2]

Nietinrijdenbord.png Stop fluoxetine
  • Before day 0: gradually reduce dosage of fluoxetine to a maximum of 20 mg/day, when this dosage is > 20 mg/day.
  • Day 1: stop administration of fluoxetine.
Eenrichtingbord.png Start hypericum

Caution is necessary.

  • Day 1-28: a wash-out period of four weeks is necessary.
  • Day 29: start administration of hypericum in a dosage of 300 mg three times a day (900 mg/day).
Infobord.png More information
  • Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.